Jacobson Mark L. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$6.52M

Insider Activity of Jacobson Mark L.

According to the SEC Form 4 filings, Jacobson Mark L., being in a position of

  1. Chief Operating Officer at Axsome Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 50128 shares for $8.9M,
    over all time since 2024-04-01, has bought 0 shares, and sold 251895 shares for $28.81M.

Biography of Jacobson Mark L.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$8,896,2624100

Comparison of Insiders on Amount of Buys and Sells

2026-09-03SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
10,000
0.0195%
$208.65$2.09M-15.67%
2026-05-05SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
233
0.0005%
$228.18$53,166-2.93%
2026-05-04SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
4,517
0.009%
$227.94$1.03M-3.18%
2026-02-26SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
35,378
0.0696%
$161.88$5.73M+27.32%
2025-09-22SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
10,000
0.0198%
$115.96$1.16M+56.57%
2025-09-16SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
45,783
0.0921%
$114.48$5.24M+60.36%
2025-06-09SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
25,000
0.051%
$110.44$2.76M+35.39%
2025-05-28SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
20,000
0.0408%
$103.45$2.07M+42.61%
2025-05-27SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
20,673
0.0423%
$104.66$2.16M+41.15%
2024-08-09SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
47,739
0.1009%
$84.26$4.02M+22.36%
2024-05-29SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
7,910
0.0165%
$74.31$587,813+23.08%
2024-04-01SaleAxsome Therapeutics, Inc.
AXSM
Chief Operating Officer
24,662
0.0522%
$77.24$1.9M+15.39%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.